To Surge or Not to Surge?
Experts Discuss Inclusion of a Surge Tank in an End-to-End Continuous Biomanufacturing Train
New Blood: Former Novartis Exec Transitions to Rubius Therapeutics
New Red-Blood-Cell-Derived Therapies Are Poised to Launch Rubius into the Spotlight.
Improving Human Health: The Promise of Epigenetics
A New Perspective for Genomic Research from Prof. Shankar Balsubramanian
Translating Innovation into Therapies
Antimicrobial Resistance and Drug Commercialization Were Key Topics at the Recent ON Helix Conference in Cambridge, U.K.
For full access to this article login to GEN Select now.
Genome Editing Explores New Depths
Classical Gene Therapy Went Through a Difficult Period, New Methodologies Are Maturing More Quickly
- Classical gene therapy took several decades to advance from proof of concept to clinical applications. In contrast, newer forms of gene therapy, such as those exploiting the CRISPR-Cas9 gene-editing system, may take less than a single decade to do the same. It may seem puzzling that the new ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.